Aptiv Solutions and Cancer Genetics, Inc. Form Strategic Partnership Focused On Creating More Effective Clinical Trials in Oncology
3/23/2011 8:29:51 AM
GREAT FALLS, Va.--(BUSINESS WIRE)--Aptiv Solutions and Cancer Genetics, Inc. (CGI) have formed a strategic partnership focused on delivering comprehensive solutions to biopharmaceutical and medical device firms conducting clinical trials for oncology therapeutics. Aptiv Solutions provides a portfolio of innovative services including adaptive trial design, early phase product strategy, regulatory services, pharmacovigilance, and the operational support of a global clinical research organization. CGI provides disease-specific biomarker knowledge, proprietary molecular testing and oncology lab services to sponsor companies during the early stages of clinical trials.
comments powered by